Global Radiopharmaceutical Market Research Report 2021
Global Radiopharmaceutical Market Research Report 2021
Get latest Market Research Reports on Radiopharmaceutical. Industry analysis and Market Report on Radiopharmaceutical is a syndicated market report, published as Global Radiopharmaceutical Market Research Report . It is complete Research Study and Industry Analysis of Radiopharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Radiopharmaceutical Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Radiopharmaceutical Market Overview:
Global Radiopharmaceutical Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Radiopharmaceutical involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Radiopharmaceutical Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Radiopharmaceutical market in 2020.
Global Radiopharmaceutical Market Segmentation
By Type, Radiopharmaceutical market has been segmented into:
SPECT Radioisotopes
PET Radioisotopes
Other Diagnostic Radioisotopes
Therapeutic Radioisotopes
By Application, Radiopharmaceutical market has been segmented into:
Oncology
Cardiology
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Radiopharmaceutical market are:
Bayer
Triad Isotopes
Lantheus
GE Healthcare
Mallinckrodt
Eli Lilly
Bracco Imaging
SIEMENS
Navidea
Nordion
IBA Group
Jubilant Pharma
1. Market Overview of Radiopharmaceutical
1.1 Radiopharmaceutical Market Overview
1.1.1 Radiopharmaceutical Product Scope
1.1.2 Market Status and Outlook
1.2 Radiopharmaceutical Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Radiopharmaceutical Historic Market Size by Regions (2015-2020)
1.4 Radiopharmaceutical Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Radiopharmaceutical Sales Market by Type (2015-2026)
2.1 Global Radiopharmaceutical Historic Market Size by Type (2015-2020)
2.2 Global Radiopharmaceutical Forecasted Market Size by Type (2021-2026)
2.3 SPECT Radioisotopes
2.4 PET Radioisotopes
2.5 Other Diagnostic Radioisotopes
2.6 Therapeutic Radioisotopes
3. Covid-19 Impact Radiopharmaceutical Sales Market by Application (2015-2026)
3.1 Global Radiopharmaceutical Historic Market Size by Application (2015-2020)
3.2 Global Radiopharmaceutical Forecasted Market Size by Application (2021-2026)
3.3 Oncology
3.4 Cardiology
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Radiopharmaceutical Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Radiopharmaceutical Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Radiopharmaceutical Business
5.1 Bayer
5.1.1 Bayer Company Profile
5.1.2 Bayer Radiopharmaceutical Product Specification
5.1.3 Bayer Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Triad Isotopes
5.2.1 Triad Isotopes Company Profile
5.2.2 Triad Isotopes Radiopharmaceutical Product Specification
5.2.3 Triad Isotopes Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Lantheus
5.3.1 Lantheus Company Profile
5.3.2 Lantheus Radiopharmaceutical Product Specification
5.3.3 Lantheus Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 GE Healthcare
5.4.1 GE Healthcare Company Profile
5.4.2 GE Healthcare Radiopharmaceutical Product Specification
5.4.3 GE Healthcare Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Mallinckrodt
5.5.1 Mallinckrodt Company Profile
5.5.2 Mallinckrodt Radiopharmaceutical Product Specification
5.5.3 Mallinckrodt Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Eli Lilly
5.6.1 Eli Lilly Company Profile
5.6.2 Eli Lilly Radiopharmaceutical Product Specification
5.6.3 Eli Lilly Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Bracco Imaging
5.7.1 Bracco Imaging Company Profile
5.7.2 Bracco Imaging Radiopharmaceutical Product Specification
5.7.3 Bracco Imaging Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 SIEMENS
5.8.1 SIEMENS Company Profile
5.8.2 SIEMENS Radiopharmaceutical Product Specification
5.8.3 SIEMENS Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Navidea
5.9.1 Navidea Company Profile
5.9.2 Navidea Radiopharmaceutical Product Specification
5.9.3 Navidea Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Nordion
5.10.1 Nordion Company Profile
5.10.2 Nordion Radiopharmaceutical Product Specification
5.10.3 Nordion Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 IBA Group
5.11.1 IBA Group Company Profile
5.11.2 IBA Group Radiopharmaceutical Product Specification
5.11.3 IBA Group Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Jubilant Pharma
5.12.1 Jubilant Pharma Company Profile
5.12.2 Jubilant Pharma Radiopharmaceutical Product Specification
5.12.3 Jubilant Pharma Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Radiopharmaceutical Market Size (2015-2026)
6.2 North America Radiopharmaceutical Key Players in North America (2015-2020)
6.3 North America Radiopharmaceutical Market Size by Type (2015-2020)
6.4 North America Radiopharmaceutical Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Radiopharmaceutical Market Size (2015-2026)
7.2 East Asia Radiopharmaceutical Key Players in North America (2015-2020)
7.3 East Asia Radiopharmaceutical Market Size by Type (2015-2020)
7.4 East Asia Radiopharmaceutical Market Size by Application (2015-2020)
8. Europe
8.1 Europe Radiopharmaceutical Market Size (2015-2026)
8.2 Europe Radiopharmaceutical Key Players in North America (2015-2020)
8.3 Europe Radiopharmaceutical Market Size by Type (2015-2020)
8.4 Europe Radiopharmaceutical Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Radiopharmaceutical Market Size (2015-2026)
9.2 South Asia Radiopharmaceutical Key Players in North America (2015-2020)
9.3 South Asia Radiopharmaceutical Market Size by Type (2015-2020)
9.4 South Asia Radiopharmaceutical Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Radiopharmaceutical Market Size (2015-2026)
10.2 Southeast Asia Radiopharmaceutical Key Players in North America (2015-2020)
10.3 Southeast Asia Radiopharmaceutical Market Size by Type (2015-2020)
10.4 Southeast Asia Radiopharmaceutical Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Radiopharmaceutical Market Size (2015-2026)
11.2 Middle East Radiopharmaceutical Key Players in North America (2015-2020)
11.3 Middle East Radiopharmaceutical Market Size by Type (2015-2020)
11.4 Middle East Radiopharmaceutical Market Size by Application (2015-2020)
12. Africa
12.1 Africa Radiopharmaceutical Market Size (2015-2026)
12.2 Africa Radiopharmaceutical Key Players in North America (2015-2020)
12.3 Africa Radiopharmaceutical Market Size by Type (2015-2020)
12.4 Africa Radiopharmaceutical Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Radiopharmaceutical Market Size (2015-2026)
13.2 Oceania Radiopharmaceutical Key Players in North America (2015-2020)
13.3 Oceania Radiopharmaceutical Market Size by Type (2015-2020)
13.4 Oceania Radiopharmaceutical Market Size by Application (2015-2020)
14. South America
14.1 South America Radiopharmaceutical Market Size (2015-2026)
14.2 South America Radiopharmaceutical Key Players in North America (2015-2020)
14.3 South America Radiopharmaceutical Market Size by Type (2015-2020)
14.4 South America Radiopharmaceutical Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Radiopharmaceutical Market Size (2015-2026)
15.2 Rest of the World Radiopharmaceutical Key Players in North America (2015-2020)
15.3 Rest of the World Radiopharmaceutical Market Size by Type (2015-2020)
15.4 Rest of the World Radiopharmaceutical Market Size by Application (2015-2020)
16 Radiopharmaceutical Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Radiopharmaceutical Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|